Apr 11 |
Charles River (CRL) Forges Collaboration With Ship of Theseus
|
Apr 11 |
Charles River and Deciphex Launch Patholytix Foresight, a Transformative AI-Powered Decision Support Tool for Toxicologic Pathology
|
Apr 9 |
Charles River, Axovia to collaborate on gene therapy development
|
Apr 9 |
Charles River Announces Rare Disease Gene Therapy Collaboration with Axovia Therapeutics
|
Apr 4 |
Charles River to Perform Plasmid Production for Ship of Theseus
|
Apr 1 |
Charles River Laboratories International, Inc.'s (NYSE:CRL) Stock Is Going Strong: Is the Market Following Fundamentals?
|
Apr 1 |
Charles River Laboratories Showcases Technology-Driven Capabilities at AACR 2024
|
Mar 27 |
Charles River Laboratories Publishes 2023 Corporate Citizenship Report
|
Mar 26 |
Charles River (CRL) Extends Gene Therapy Deal With NUS Medicine
|
Mar 23 |
U.S.-China Decoupling Poses Supply-Chain Risks for Drug Companies
|